Here are what the editors at HealthDay consider to be the most important developments in Urology for July 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Specialties See Modest Compensation Increases in '09
FRIDAY, July 30 (HealthDay News) -- Most medical specialties saw modest compensation increases in 2009, but many provider organizations are still operating at a substantial loss, according to the findings of the American Medical Group Association's (AMGA) 2010 Medical Group Compensation and Financial Survey.
More Information
Sipuleucel-T Linked to Prostate Cancer Survival Benefit
WEDNESDAY, July 28 (HealthDay News) -- Sipuleucel-T -- a therapeutic cancer vaccine -- is associated with prolonged overall survival in men with metastatic castration-resistant prostate cancer, but without a longer time to disease progression, according to research published in the July 29 issue of the New England Journal of Medicine.
Full Text (subscription or payment may be required)
Behavioral Training Doesn't Help Incontinence Outcomes
WEDNESDAY, July 28 (HealthDay News) -- Women who are on drug therapy for urge urinary incontinence do not improve their outcomes by adding behavioral intervention to their treatment program, according to a study in the August issue of The Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
Nerve Stimulation Helps Control Overactive Bladder in Kids
WEDNESDAY, July 28 (HealthDay News) -- Parasacral transcutaneous electrical nerve stimulation (PTENS) appears effective for treating overactive bladder in children, according to research published in the August issue of The Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
Medicare Data Show Variation in Prostate Cancer Care
WEDNESDAY, July 28 (HealthDay News) -- Continuing care for Medicare beneficiaries with prostate cancer is associated with considerable variation, suggesting unnecessarily high expenditures for the health care system, according to research published in the August issue of The Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
Docs, Prostate Patients Show Agreement on Adverse Events
TUESDAY, July 27 (HealthDay News) -- Physicians tend to note pelvic-related adverse events in reasonable accordance with patients receiving hormone manipulation or external beam radiation therapy (EBRT) for prostate cancer, according to research published in the August issue of The Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
Many With Low-Risk Prostate Cancer Get Aggressive Therapy
MONDAY, July 26 (HealthDay News) -- Most men diagnosed with prostate cancer who have a prostate-specific antigen (PSA) threshold below 4.0 ng/mL undergo aggressive local therapy despite having low-risk disease, according to research published in the July 26 issue of the Archives of Internal Medicine.
Abstract
Full Text (subscription or payment may be required)
Comment (subscription or payment may be required)
Radiation May Decrease Rate of Gynecomastia in Prostate Cases
MONDAY, July 26 (HealthDay News) -- Prophylactic breast irradiation may decrease the rate of gynecomastia in prostate cancer patients receiving bicalutamide; however, with a relatively low number of men significantly bothered by this issue, not all patients need this prophylaxis, according to research published in the August issue of The Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
Pelvic Radiation in Girls Tied to Higher Stillbirth Risk
FRIDAY, July 23 (HealthDay News) -- Female survivors of childhood cancer treated with pelvic radiation have a much higher risk of stillbirth and neonatal death in their offspring than do females who did not get radiation, but there is no increased risk for male survivors who received gonadal radiation, according to research published online July 23 in the The Lancet.
Abstract
Full Text (subscription or payment may be required)
Modest Weight Loss Linked to Urinary Incontinence Benefits
FRIDAY, July 23 (HealthDay News) -- In overweight and obese women, modest weight loss can result in significant urinary incontinence benefits, according to a study in the August issue of Obstetrics & Gynecology.
Full Text
Multiple Genetic Variants Add to Prostate Cancer Risk
FRIDAY, July 23 (HealthDay News) -- Nine genetic variants located in different regions have a cumulative association with risk of developing prostate cancer, according to a study in the August issue of The Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
5.2 Percent of Residency Applicant Essays Plagiarized
TUESDAY, July 20 (HealthDay News) -- About 5 percent of the application essays to residency programs -- often referred to as the personal statement -- contain plagiarized material, according to research published in the July 20 issue of the Annals of Internal Medicine.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Painters Found to Have Increased Bladder Cancer Risk
TUESDAY, July 20 (HealthDay News) -- Occupational exposures in painters are associated with an elevated risk for bladder cancer, a risk that increases with years on the job, according to research published in the August issue of Occupational and Environmental Medicine.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Surgical Residents' Fellowship Decisions Are Gender-Neutral
MONDAY, July 19 (HealthDay News) -- A surgery resident's decision to pursue fellowship training is largely due to a desire for clinical mastery and specialty activities regardless of gender, with lifestyle factors of only midrange importance and program size appearing more influential than gender, according to research published in the July issue of the Archives of Surgery.
Abstract
Full Text (subscription or payment may be required)
Depression Linked to Erectile Dysfunction May Raise CV Risk
MONDAY, July 19 (HealthDay News) -- Depressive symptoms in men with erectile dysfunction (ED) constitute an independent risk factor for the incidence of a major cardiovascular event (MACE), according to a study published online July 13 in the Journal of Sexual Medicine.
Abstract
Full Text (subscription or payment may be required)
Many Doctors in Specialties Other Than Their Early Choices
WEDNESDAY, July 7 (HealthDay News) -- Ten years after graduation, approximately one-fourth of doctors work in a specialty other than the one they chose in their third year post-graduation, according to research published online July 6 in BMJ.
Abstract
Full Text
Editorial
Users of ED Drugs Have Higher Rates of Sexual Diseases
TUESDAY, July 6 (HealthDay News) -- Men using medication for erectile dysfunction (ED) have higher rates of sexually transmitted diseases (STDs) -- especially HIV infection -- both before and after using these drugs, according to research published in the July 6 issue of the Annals of Internal Medicine.
Abstract
Full Text (subscription or payment may be required)
Second Opinion May Be Warranted Before Prostatectomy
MONDAY, July 5 (HealthDay News) -- A mandatory second opinion to interpret prostate needle biopsy prior to radical prostatectomy in a few cases results in differences that may affect therapy, according to research published in the July issue of the The Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
TMP-SMX Associated With Hyperkalemia in Elderly
FRIDAY, July 2 (HealthDay News) -- Older patients taking trimethoprim-sulfamethoxazole (TMP-SMX) have a substantially increased risk of hyperkalemia requiring hospitalization, but being on β-blockers does not further increase this risk, according to research published online July 1 in the Clinical Journal of the American Society of Nephrology.
Abstract
Full Text (subscription or payment may be required)
Report Addresses Physician Financial Conflicts in Care
THURSDAY, July 1 (HealthDay News) -- In a new report, the Association of American Medical Colleges (AAMC) urges U.S. teaching hospitals to establish policies that ensure financial relationships between physicians and industry do not result in conflicts of interest that influence patient care.
Press Release
Switching Prostate Meds Can Drive Up PSA Velocity
THURSDAY, July 1 (HealthDay News) -- In patients with benign prostatic hyperplasia (BPH), switching from one 5α-reductase inhibitor to another can result in a significant change in prostate-specific antigen (PSA) velocity that may prompt physicians to order unnecessary biopsies, according to research published in the July issue of The Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
PSA Program Linked to Less Prostate Cancer Mortality
THURSDAY, July 1 (HealthDay News) -- A prostate-specific antigen (PSA)-based screening program is associated with a reduction in prostate cancer mortality of nearly half over 14 years, but with a substantial risk of overdiagnosis, according to research published online July 1 in The Lancet Oncology.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
